Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity = Emodin의 암세포 이동저해 효과

Cited 31 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorYoung Min Han-
dc.contributor.authorS K Lee-
dc.contributor.authorDae Gwin Jeong-
dc.contributor.authorS E Ryu-
dc.contributor.authorDong Cho Han-
dc.contributor.authorD K Kim-
dc.contributor.authorByoung-Mog Kwon-
dc.date.accessioned2017-04-19T09:27:29Z-
dc.date.available2017-04-19T09:27:29Z-
dc.date.issued2012-
dc.identifier.issn0960-894X-
dc.identifier.uri10.1016/j.bmcl.2011.11.008ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/10485-
dc.description.abstractAnthraquinones have been reported as phosphatase inhibitors. Therefore, anthraquinone derivatives were screened to identify a potent phosphatase inhibitor against the phosphatase of regenerating liver-3 (PRL-3). Emodin strongly inhibited phosphatase activity of PRL-3 with IC 50 values of 3.5 μM and blocked PRL-3-induced tumor cell migration and invasion in a dose-dependent manner. Emodin rescued the phosphorylation of ezrin, which is a known PRL-3 substrate. The results of this study reveal that emodin is a PRL-3 inhibitor and a good lead molecule for obtaining a selective PRL-3 inhibitor.-
dc.publisherElsevier-
dc.titleEmodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity = Emodin의 암세포 이동저해 효과-
dc.title.alternativeEmodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity-
dc.typeArticle-
dc.citation.titleBioorganic & Medicinal Chemistry Letters-
dc.citation.number1-
dc.citation.endPage326-
dc.citation.startPage323-
dc.citation.volume22-
dc.contributor.affiliatedAuthorYoung Min Han-
dc.contributor.affiliatedAuthorDae Gwin Jeong-
dc.contributor.affiliatedAuthorDong Cho Han-
dc.contributor.affiliatedAuthorByoung-Mog Kwon-
dc.contributor.alternativeName한영민-
dc.contributor.alternativeName이수경-
dc.contributor.alternativeName정대균-
dc.contributor.alternativeName류성언-
dc.contributor.alternativeName한동초-
dc.contributor.alternativeName김대근-
dc.contributor.alternativeName권병목-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry Letters, vol. 22, no. 1, pp. 323-326-
dc.identifier.doi10.1016/j.bmcl.2011.11.008-
dc.subject.keywordEmodin-
dc.subject.keywordInvasion-
dc.subject.keywordMetastasis-
dc.subject.keywordMigration-
dc.subject.keywordPRL-3-
dc.subject.localEmodin-
dc.subject.localemodin-
dc.subject.localinvasion-
dc.subject.localInvasion-
dc.subject.localmetastasis-
dc.subject.localMetastasis-
dc.subject.localMigration-
dc.subject.localmigration-
dc.subject.localPRL-3-
dc.description.journalClassY-
Appears in Collections:
Division of Research on National Challenges > Bionanotechnology Research Center > 1. Journal Articles
Division of A.I. & Biomedical Research > Genomic Medicine Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.